Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancer

This publication has 14 references indexed in Scilit:

• Hepatocellular damage by cyproterone acetate
  European Journal of Cancer and Clinical Oncology, 1986
• Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women
  European Journal of Cancer and Clinical Oncology, 1986
• Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients
  Cancer Chemotherapy and Pharmacology, 1984
• Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects
  European Journal of Cancer and Clinical Oncology, 1984
• Cyproteroneacetate and ACTH Adrenal Function*
  Journal of Clinical Endocrinology & Metabolism, 1978
• Pharmacokinetic Consequences of Aging
  Annual Review of Pharmacology and Toxicology, 1977
• Bio-availability and pharmacokinetics of cyproterone acetate-14C and ethinyloestradiol-3H after oral administration as a coated tablet (SH B 209 AB)
  Contraception, 1976
• Experience in the Treatment of Prostatic Carcinoma with Cyproterone Acetate
  Journal of Urology, 1973
• Behandlung des Hirsutismus mit Cyproteronacetat^*
  Deutsche Medizinische Wochenschrift (1946), 1969
• Progesterone oral contraception and blood coagulation.
  BMJ, 1969